Safety Profile of JAK Inhibitors and their Use in Atopic Dermatitis
Experts on atopic dermatitis compare the safety profile of JAK inhibitors with traditional and more advanced treatments currently available for patients.
EP: 1.Heterogenous Presentation of Atopic Dermatitis
EP: 2.Burden of Atopic Dermatitis and its Impact on Patient’s Quality of Life
EP: 3.Patient’s Goals and Atopic Dermatitis Treatment Selection
EP: 4.Talking to Patients about Atopic Dermatitis Treatment Response
EP: 5.Use of PRO in Atopic Dermatitis Clinical Practice
EP: 6.Incorporating Patient Preferences in the Treatment of Atopic Dermatitis
EP: 7.Changing Standard of Care in Atopic Dermatitis
EP: 8.Unmet Needs and Gaps in AD
EP: 9.Looking Beyond Type 2 Inflammation in Atopic Dermatitis
EP: 10.JAK Inhibitors in Atopic Dermatitis
Now Viewing
EP: 11.Safety Profile of JAK Inhibitors and their Use in Atopic Dermatitis
EP: 12.Monitoring Schedule for JAK Inhibitors in Atopic Dermatitis
Video content above is prompted by the following:
- Discuss safety of JAKi compared to traditional and more advanced treatments for atopic dermatitis.
- Boxed warning for JAKi
- What are primary concerns for physicians and patients?
Recent Videos
Related Content
